Business
Exercise of share options and total voting rights
Exercise of share options and total voting rights.
About this update from Fusion Antibodies Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 7950V\n Fusion Antibodies PLC\n 16 December 2021\n \n \n \n 16 December 2021\n \n Fusion Antibodies plc\n (\"Fusion\" or the \"Company\")\n \n Exercise of share options and total voting rights\n \n \n Fusion Antibodies plc (AIM: FAB), \n specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces an exercise of share options in the Company (\"Ordinary Shares\") by Sonya Ferguson, Non-Executive Director of the Company.\n \n \n \n On 15 December 2021, Sonya Ferguson exercised 25,000 share options. These historic share options were granted prior to the Company's admission to trading on AIM and with an exercise price of 4 pence per share. The new Ordinary Shares issued pursuant to this exercise will be admitted to trading on AIM pursuant to the Block Admission announced by the Company on 27 September 2021. The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.\n \n \n \n Following the above exercise of 25,000 share options, Sonya Ferguson holds 92,567 Ordinary Shares, representing approximately 0.35 per cent. of the Company's enlarged issued share capital. \n \n \n Following the exercise of share options, the total number of Ordinary Shares in issue is now 25,963,280. The Company does not currently hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 25,963,280, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules. \n \n The following notification, made in accordance with the requirements of the UK Market Abuse Regulation, gives further details. \n \n \n \n 1\n \n \n Details of the person discharging managerial responsibilities / person closely associated\n \n \n \n \n a)\n \n \n Name\n \n \n \n Sonya Ferguson\n \n \n \n \n \n 2\n \n \n Reason for the notification\n \n \n \n \n a)\n \n \n Position/status\n \n \n Non-Executive Director\n \n \n \n \n b) \n \n \n Initial notification /Amendment\n \n \n Initial notification\n \n \n \n \n 3&...